Neurology Ultrasonic Aspirators are classified primarily by device architecture into three distinct types: handheld, cart‑based, and robotic‑assisted systems. Handheld units integrate the ultrasonic transducer and suction channel within a single ergonomic probe, enabling surgeons to maneuver within confined cranial corridors; they account for roughly 40 % of total shipments because of lower capital cost and ease of adoption in midsize neurosurgical centers. Cart‑based platforms separate the power supply, control console, and fluid management from the handpiece, offering higher power output and extended duty cycles; these systems dominate the high‑volume segment, contributing approximately 45 % of market revenue, particularly in tertiary hospitals where complex tumor resections demand sustained ultrasonic energy. Robotic‑assisted aspirators incorporate motion‑control algorithms and image‑guided navigation, providing sub‑millimetre precision and reduced operator fatigue; despite a premium price, they capture an emerging 15 % share driven by academic institutions investing in advanced neurosurgical research. Collectively, the type segmentation delineates cost‑structure, adoption barriers, and revenue distribution across the Neurology Ultrasonic Aspirators market.